Xavier Preville

Title: Xavier Preville: Innovator in Immunotherapy

Introduction

Xavier Preville is a notable inventor based in Pins-Justaret, France. He has made significant contributions to the field of immunotherapy, particularly in the development of compositions aimed at eliciting specific cytotoxic T lymphocyte (CTL) responses. His innovative work has the potential to impact anti-infection and anti-cancer therapies.

Latest Patents

Xavier Preville holds a patent for a composition designed to elicit a specific CTL response. This composition comprises a lympho-ablative compound and a molecule that contains antigenic sequences, targeting professional antigen presenting cells. The invention relates to a method for provoking lymphocytopenia and enhancing the immune response against T cell epitopes in mammals. The composition may also include an adjuvant and is applicable in therapeutic contexts for infections and cancer.

Career Highlights

Xavier Preville is associated with Genticel, a company focused on innovative biopharmaceutical solutions. His work at Genticel has allowed him to explore and develop groundbreaking approaches in immunotherapy. With a patent portfolio that includes 1 patent, he continues to push the boundaries of medical science.

Collaborations

Xavier collaborates with Benedikt Timmerman, contributing to the advancement of their shared goals in the field of immunotherapy. Their partnership exemplifies the collaborative spirit essential for innovation in research and development.

Conclusion

Xavier Preville is a distinguished inventor whose work in immunotherapy holds promise for future medical advancements. His contributions, particularly through his patent, reflect a commitment to improving therapeutic strategies against infections and cancer.